Open Access

Are we prepared to reduce LDL-cholesterol at any cost?

Event: ESC CONGRESS 2017
Topic: Drug therapy
Session type: Satellite Symposium
Sponsored by Mylan
Date: 29 August 2017
Time: 12:45 - 13:45

Session

5 presentations in this session

Challenges for reaching LDL-C goals in high and very high risk patients.

Speaker: Professor L. Tokgozoglu (Ankara, TR)
Thumbnail

High potency statins and beyond: benefits of combination therapy.

Speaker: Doctor M. Farnier (Dijon, FR)
Thumbnail

Last step on the ladder: proprotein convertase subtilisin/kexin type 9 (PCSK9).

Speaker: Professor L. Tokgozoglu (Ankara, TR)
Thumbnail

Cost implications of misunderstanding statin intolerance.

Speaker: Professor E. Stroes (Amsterdam, NL)
Thumbnail

Conclusion - Are we prepared to reduce LDL-cholesterol at any cost?

Speaker: Professor L. Tokgozoglu (Ankara, TR)
Thumbnail

5 speakers from this session

Professor Lale Tokgozoglu

Hacettepe University, Ankara (Turkey)
23 presentations
0 follower

Doctor Michel Farnier

University of Bourgogne Franche Comte, Dijon (France)
7 presentations
0 follower

Professor Lale Tokgozoglu

Hacettepe University, Ankara (Turkey)
23 presentations
0 follower

Professor Erik Stroes

Academic Medical Center of Amsterdam, Amsterdam (Netherlands (The))
17 presentations
0 follower

Professor Lale Tokgozoglu

Hacettepe University, Ankara (Turkey)
23 presentations
0 follower

This platform is supported by

logo Novo Nordisk